Finance

Beta

Lists

Equity sectors
Symbols
Symbols
Trend
Change
Price
Change
% Change
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.45%
—
1,097.08
-0.45%
1,097.08
-5.00
-0.45%
1,102.081,104.411,110.611,096.10——
SIXC
Communications
SIXC
Communications
SIXC
+0.27%
—
571.79
+0.27%
571.79
+1.56
+0.27%
570.23570.23576.23566.53——
SIXE
Energy
SIXE
Energy
SIXE
-1.69%
—
1,124.31
-1.69%
1,124.31
-19.27
-1.69%
1,143.581,137.641,137.641,113.91——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.72%
—
1,820.63
+0.72%
1,820.63
+12.95
+0.72%
1,807.681,814.861,840.041,814.86——
SIXM
Financials
SIXM
Financials
SIXM
-0.91%
—
658.84
-0.91%
658.84
-6.03
-0.91%
664.87667.28670.86657.59——
SIXR
Staples
SIXR
Staples
SIXR
-0.49%
—
837.82
-0.49%
837.82
-4.10
-0.49%
841.92841.46843.77836.31——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.29%
—
214.08
-0.29%
214.08
-0.63
-0.29%
214.71214.71216.26213.98——
SIXT
Technology
SIXT
Technology
SIXT
+3.08%
—
3,853.63
+3.08%
3,853.63
+115.02
+3.08%
3,738.613,823.543,863.533,812.59——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.66%
—
901.60
+0.66%
901.60
+5.88
+0.66%
895.72896.48913.11896.48——
SIXV
Health care
SIXV
Health care
SIXV
-0.85%
—
1,505.60
-0.85%
1,505.60
-12.95
-0.85%
1,518.551,520.111,520.981,499.19——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.51%
—
2,365.50
+1.51%
2,365.50
+35.08
+1.51%
2,330.422,343.432,374.422,332.21——
LRMR:NASDAQ
Larimar Therapeutics Inc
$3.64
+2.82%
(+0.10) Today
Closed: Jun 18, 4:00:01 PM GMT-4  ·   USD
$3.62
-0.55% (-0.020)
After hours  ·  6:54 PM
SymbolPriceChange% ChangePrev Close
Generating top insights for LRMR...
Open
$3.62
High
$3.76
Low
$3.48
Mkt. cap
378.13M
Avg. vol.
1.88M
Volume
3.30M
52-wk high
$6.42
52-wk low
$2.22
EPS
-$2.08
Beta
0.83
Shares outstanding
103.88M
No. of employees
71
Open
$3.62
High
$3.76
Low
$3.48
Mkt. cap
378.13M
Avg. vol.
1.88M
Volume
3.30M
52-wk high
$6.42
52-wk low
$2.22
EPS
-$2.08
Beta
0.83
Shares outstanding
103.88M
No. of employees
71
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to LRMR in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LRMR in the last 3 months.
Highest
Current $3.64
$25.00 (+586.81%)
Average
$15.33 (+321.15%)
Lowest
$9.00 (+147.25%)
News stories
From sources across the web
Barchart.com
Barchart.com
·
1 hour ago
Is Snap-On Stock Underperforming the S&P 500?
Insider Monkey
Insider Monkey
·
9 hours ago
Is nCino (NCNO) One Of The Stocks Under $20 That Will Explode?
Seeking Alpha
Seeking Alpha
·
1 hour ago
S&P 500 Snapshot: Peace Deal Overcomes Fed Jitters
AP News
AP News
·
2 days ago
Stocks rise on Wall Street, erasing much of their loss from a day earlier
The Motley Fool
The Motley Fool
·
9 hours ago
The Vanguard S&P 500 ETF (VOO) Is the Most Popular ETF in the World. Here's One I Like Even Better.
Simply Wall Street
Simply Wall Street
·
4 hours ago
Is Multi‑Index S&P Inclusion Altering The Investment Case For First Advantage (FA)?
Yahoo Finance
Yahoo Finance
·
1 day ago
The Stock Market Is Doing Something Not Witnessed Since the Dot-Com Bubble. Here's What History Says Comes Next.
24/7 Wall St.
24/7 Wall St.
·
15 hours ago
This Space Stock Will Beat SpaceX to the Nasdaq-100 — And It’s the One to Buy
GuruFocus
GuruFocus
·
15 hours ago
Charles Schwab (SCHW) Launches New Yes-or-No Options Tied to S&P 500
TheStreet
TheStreet
·
13 hours ago
Wells Fargo new S&P 500 target sends investors clear signal
CoinDesk
CoinDesk
·
3 days ago
Forget the price charts. Here's how bitcoin and S&P 500 look like when adjusted for the money printer
CNN
CNN
·
2 weeks ago
Nasdaq, S&P 500 suffer worst day of year as AI stocks tumble and Fed rate-hike odds rise
Show more
About Larimar Therapeutics Inc
CEO-
Employees71
Founded2005
HeadquartersBala Cynwyd, Pennsylvania, United States
SectorBiotechnology
Websitelarimartx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23.27M
44.83M
59.17M
24.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.52M
4.67M
4.84M
6.19M
Operating expense
27.79M
49.50M
64.02M
31.12M
Total operating expenses
27.79M
49.50M
64.02M
31.12M
Operating income
-27.79M
-49.50M
-64.02M
-31.12M
Other non operating income
1.61M
1.79M
1.52M
1.50M
EBT including unusual items
-26.18M
-47.71M
-62.50M
-29.61M
EBT excluding unusual items
-26.18M
-47.71M
-62.50M
-29.61M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.18M
-47.71M
-62.50M
-29.61M
Net profit margin
-
-
-
-
Earnings per share
-0.41
-0.61
-0.73
-0.31
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.70M
-49.41M
-63.93M
-31.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer